| Scherr, Daniel |
ERASE, NCT04600921: Ertugliflozin to Reduce Arrhythmic Burden in ICD/CRT patientS (ERASe-Trial) - a Phase III Study |
|
|
| Terminated | 3 | 55 | Europe | Ertugliflozin 5 mg, Steglatro, Placebo 5mg, Sugar pills | Medical University of Graz, Klinikum Klagenfurt am Wörthersee, Elisabethinen Hospital, Medical University Innsbruck, Medical University of Vienna, General Hospital Linz, Landesklinkum Wiener Neustadt, Klinik Ottakring | Heart Failure With Reduced Ejection Fraction, Heart Failure With Mid Range Ejection Fraction, Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy | 06/23 | 10/23 | | |
NCT02816047: Austrian Wearable Cardioverter Defibrillator Registry |
|
|
| Recruiting | N/A | 450 | Europe | Registry | Medical University of Graz | Heart Failure, Ventricular Dysfunction, Sudden Death, Sudden Cardiac Arrest, Ventricular Tachycardia, Ventricular Fibrillation | 12/21 | 03/22 | | |
| Recruiting | N/A | 10 | Europe | Stereotactic Antiarrhythmic Radiotherapy | Medical University of Graz | Ventricular Arrythmia | 02/27 | 02/27 | | |
| Active, not recruiting | N/A | 1686 | Europe, Canada, Japan, US, RoW | SyncAV programmed ON, Fixed AV delay | Abbott Medical Devices | Congestive Heart Failure | 06/25 | 12/25 | | |
NCT03409159: Austrian Left Atrial Appendage Closure Registry |
|
|
| Recruiting | N/A | 200 | Europe | LAAC | Medical University of Graz | Atrial Fibrillation, Left Atrial Appendage Closure | 05/24 | 05/24 | | |
| Active, not recruiting | N/A | 292 | Europe, RoW | PVI using PEF, PVI using CFRF | University Hospital, Bordeaux, Funding: European Commission (H2020) | Atrial Fibrillation | 02/25 | 02/25 | | |
| Active, not recruiting | N/A | 119 | Europe | image-guided VT ablation strategy, conventional VT ablation strategy | University Hospital, Bordeaux, EIT Health | Ventricular Tachycardia | 03/24 | 03/25 | | |
| Recruiting | N/A | 78 | Europe, RoW | PVI and Linear lesion using PEF, PVI and Linear lesion using CFRF | University Hospital, Bordeaux, Horizon 2020 - European Commission | Atrial Fibrillation | 05/25 | 05/25 | | |
| Recruiting | N/A | 615 | Europe, Canada, Japan, US, RoW | Wide Circumferential Pulmonary Vein Antrum Isolation (PVAI), Pulmonary Vein Antrum Isolation Plus Driver Ablation (PVAI+drivers), Pulmonary Vein Antrum Isolation Plus Box Isolation of Posterior Wall (PVAI+box) | McGill University Health Centre/Research Institute of the McGill University Health Centre, Montreal Heart Institute | Atrial Fibrillation | 08/26 | 01/27 | | |
SAFE-ME, NCT03357926: Prospective Database for Prediction of Atrial Fibrillation in Pacemaker and ICD Patients |
|
|
| Recruiting | N/A | 250 | Europe | 24 hour Holter ECG Monitoring | Medical University of Graz | Atrial Fibrillation, Pacemaker Ddd, ICD | 12/24 | 12/24 | | |
| Recruiting | N/A | 82 | Europe, RoW | Biventricular pacemaker implantation, Conduction system pacing device implantation, AV node ablation | University Medical Centre Ljubljana | Heart Failure, Tachycardia-induced Cardiomyopathy, Atrial Fibrillation | 12/25 | 12/26 | | |
| Odeneg, Tanja |
NCT02816047: Austrian Wearable Cardioverter Defibrillator Registry |
|
|
| Recruiting | N/A | 450 | Europe | Registry | Medical University of Graz | Heart Failure, Ventricular Dysfunction, Sudden Death, Sudden Cardiac Arrest, Ventricular Tachycardia, Ventricular Fibrillation | 12/21 | 03/22 | | |
